Patent Family
3 août 2021
Patent Family #3: Increasing the Efficiency of the C3P3 Enzyme 
The third patent family builds on the previous two and provides a highly significant boost to the efficacy of the C3P3 enzyme. Filed in 2021, it protects the innovative concept of C3P3-G3, which inhibits the critical phosphorylation of subunit A of the translation initiation factor eIF2 (eIF2a) in cells expressing mRNA synthesized by the C3P3 enzyme. By inhibiting a cellular defense mechanism against mRNA produced by the C3P3 enzyme, the G3 module complements the structure of the enzyme and dramatically improves its overall efficiency.